title: Combination chemotherapy for extensive small cell lung cancer -- experience from India.
authors.forename: D
authors.initials: D
authors.lastname: Behera
authors.forename: A N
authors.initials: AN
authors.lastname: Aggarwal
authors.forename: S C
authors.initials: SC
authors.lastname: Sharma
authors.forename: D
authors.initials: D
authors.lastname: Gupta
authors.forename: S K
authors.initials: SK
authors.lastname: Jindal
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality; D004334:Drug Administration Schedule; D016527:Drug Costs; D005047:Etoposide / Q000008:administration & dosage / Q000191:economics; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000191:economics; D007194:India; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D015080:Mesna / Q000008:administration & dosage / Q000191:economics; D008875:Middle Aged; D010349:Patient Compliance; D011203:Poverty; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage / Q000191:economics
chemical_list: D014750:Vincristine; D005047:Etoposide; D015080:Mesna; D007069:Ifosfamide